Figure 1. Putative mechanisms for vascular and renal protection by SGLT2i. SGLT2i: sodium-glucose cotransporter-2 inhibitors.
| Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
| Journal website http://www.jofem.org |
Editorial
Volume 9, Number 5, October 2019, pages 117-119
Dipeptidyl Peptidase-4 Inhibitor Versus Sodium-Glucose Cotransporter-2 Inhibitor in the Management of Type 2 Diabetes
Figure